5-methylcytosine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, C; Han, C; Liao, YQ; Lin, X; Luo, HR; Sun, Q; Tang, TS; Wang, D; Wang, F; Wang, JQ; Wu, YS; Xie, W; Yang, Y; Yang, YG; Zhu, S | 1 |
| Albasanz, JL; Barrachina, M; Blanch, M; Ferrer, I; Martín, M; Pereira-Veiga, T; Pérez-Navarro, E; Tyebji, S; Villar-Menéndez, I | 1 |
2 other study(ies) available for 5-methylcytosine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease.
Topics: 5-Methylcytosine; Animals; Brain; Corpus Striatum; Cytosine; Disease Models, Animal; DNA Methylation; Epigenomics; Humans; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Sequence Alignment; Sequence Analysis, DNA | 2013 |
Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease.
Topics: 5-Methylcytosine; 5' Untranslated Regions; Adult; Aged; Aged, 80 and over; Animals; Corpus Striatum; Cytosine; Disease Models, Animal; Disease Progression; DNA Methylation; Down-Regulation; Female; Gene Expression Regulation; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Transgenic; Middle Aged; Nerve Tissue Proteins; Putamen; Receptor, Adenosine A2A | 2013 |